| Ytd | -25.93% | |
| 1y | 79.65% |
| Open | 1.31 | Prev Close | 1.31 | Low | 1.19 | High | 1.44 | Mkt Cap | 8.42M |
| Vol | 605.48K | Avg Vol | 96.35K | EPS | 0.67 | P/E | 1.79 | Forward P/E | N/A |
| Beta | 0.68 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.24 | 200-d Avg | 1.58 | 1yr Est | 0.00 |
MBAI News
U.S. stock futures were mixed on Monday, as the Dow Jones index slipped and the S&P 500 and Nasd
U.S. stock futures mixed, Aecom and Hawaiian Electric report earnings, Alcon expected to release ear
Check-Cap Ltd. ("Check-Cap" or the "Company") (NASDAQ:MBAI) today announced a 1-for-
ISFIYA, Israel, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (“Check-Cap” or the “Company”) (NAS
Nasdaq-listed Check-Cap (NASDAQ: MBAI): MBody AI secures exclusive U.S. rights to outdoor cleaning r
Check-Cap Ltd. ("Check-Cap" or the "Company") (NASDAQ: MBAI) today updated the expec
Check-Cap Ltd. (NASDAQ: MBAI) has publicly filed its Form F-1 and now expects its merger with MBody
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday&
ISFIYA, Israel and LAS VEGAS, July 16, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (“Check-Cap” or the “
Check-Cap Ltd. ("Check-Cap" or the "Company") (NASDAQ:MBAI) today announced that MBo
Check-Cap ($MBAI): MBody AI signed a referral/channel deal with Buyers Edge, expanding access to ~28
Check-Cap (NASDAQ: MBAI - Get Free Report) and Bioventus (NASDAQ: BVS - Get Free Report) are both sm
Check-Cap (NASDAQ: MBAI - Get Free Report) and TransEnterix (OTCMKTS:TRXDW - Get Free Report) are bo
Nanovibronix (NASDAQ: FEED - Get Free Report) and Check-Cap (NASDAQ: MBAI - Get Free Report) are bot
Carlsmed (NASDAQ: CARL - Get Free Report) and Check-Cap (NASDAQ: MBAI - Get Free Report) are both sm
Check-Cap (NASDAQ: MBAI - Get Free Report) and Longevity Health (NASDAQ: XAGE - Get Free Report) are
ISFIYA, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (NASDAQ: MBAI) ("Check-Cap" or the
Check-Cap (NASDAQ: MBAI - Get Free Report) and Carlsmed (NASDAQ: CARL - Get Free Report) are both sm
Check-Cap Ltd. (NASDAQ:MBAI) ("Check-Cap" or the "Company") today announced key regu
Check-Cap Ltd. (NASDAQ:MBAI) ("Check-Cap" or the "Company") today announced that it
Las Vegas, Nevada and Isfiya, Israel--(Newsfile Corp. - December 1, 2025) - MBody AI Corp. ("MBody A
